Page last updated: 2024-08-23

staurosporine and isatin beta-thiosemicarbazone

staurosporine has been researched along with isatin beta-thiosemicarbazone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fales, HM; Gottesman, MM; Hall, MD; Hellawell, JL; Hibbs, DE; Kensler, CB; Ludwig, JA; Salam, NK; Szakács, G	1
Dou, X; Jiang, L; Jin, H; Liu, Z; Wang, Y; Zhang, L	1

Other Studies

2 other study(ies) available for staurosporine and isatin beta-thiosemicarbazone

Article	Year
Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. Journal of medicinal chemistry, 2009, May-28, Volume: 52, Issue:10 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Cytotoxins; Drug Resistance, Multiple; Enzyme Inhibitors; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Isatin; Quantitative Structure-Activity Relationship; Substrate Specificity	2009
Discovery of new GSK-3β inhibitors through structure-based virtual screening. Bioorganic & medicinal chemistry letters, 2018, 01-15, Volume: 28, Issue:2 Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship	2018

Article

Year

Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.

Journal of medicinal chemistry, 2009, May-28, Volume: 52, Issue:10

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Cytotoxins; Drug Resistance, Multiple; Enzyme Inhibitors; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Isatin; Quantitative Structure-Activity Relationship; Substrate Specificity

2009

Discovery of new GSK-3β inhibitors through structure-based virtual screening.

Bioorganic & medicinal chemistry letters, 2018, 01-15, Volume: 28, Issue:2

Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship

2018